Business Wire

AIRNA Raises Oversubscribed $60 Million Financing to Advance New Class of RNA Editing ...

CAMBRIDGE, Mass. & TÜBINGEN, Germany--(BUSINESS WIRE)--AIRNA, a biotech company pioneering RNA editing therapeutics to restore the health of patients with rare and common diseases, today announced the ...
Business Wire

AIRNA Launches to Develop New Class of RNA Editing Therapeutics for Rare and Common Diseases

CAMBRIDGE, Mass. & TÜBINGEN, Germany--(BUSINESS WIRE)--AIRNA, a biotech company pioneering RNA editing therapeutics to restore the health of patients with rare and common diseases, today emerged from ...
Nasdaq

Precision BioSciences Receives U.S. FDA Fast Track Designation for PBGENE-HBV, a First-In ...

DURHAM, N.C.--(BUSINESS WIRE)-- Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing ...